Cargando…
The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitro.
Carboxypeptidase G2, a zinc metalloenzyme isolated from Pseudomonas sp. strain RS-16, which catalyses the hydrolytic cleavage of reduced and non-reduced folates to pteroates and L-glutamate, has been linked to a monoclonal antibody (W14A) raised to human chorionic gonadotrophin. The coupling efficie...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001364/ https://www.ncbi.nlm.nih.gov/pubmed/3964540 |
_version_ | 1782135590245892096 |
---|---|
author | Searle, F. Bier, C. Buckley, R. G. Newman, S. Pedley, R. B. Bagshawe, K. D. Melton, R. G. Alwan, S. M. Sherwood, R. F. |
author_facet | Searle, F. Bier, C. Buckley, R. G. Newman, S. Pedley, R. B. Bagshawe, K. D. Melton, R. G. Alwan, S. M. Sherwood, R. F. |
author_sort | Searle, F. |
collection | PubMed |
description | Carboxypeptidase G2, a zinc metalloenzyme isolated from Pseudomonas sp. strain RS-16, which catalyses the hydrolytic cleavage of reduced and non-reduced folates to pteroates and L-glutamate, has been linked to a monoclonal antibody (W14A) raised to human chorionic gonadotrophin. The coupling efficiency and retention of antibody and enzymatic activities are compared for three separate methods of preparing 1:1 conjugates. Preliminary in vitro studies on the cytotoxicity of the free enzyme and the conjugated enzyme towards JAR choriocarcinoma cells are reported. Despite the limitations of the in vitro model, it could be demonstrated that a significant proportion of 10(6) choriocarcinoma cells lost viability when exposed to either free or conjugated enzyme for 72 hours at concentrations of carboxypeptidase G2 of 1-3 units ml-1 of medium. |
format | Text |
id | pubmed-2001364 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1986 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20013642009-09-10 The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitro. Searle, F. Bier, C. Buckley, R. G. Newman, S. Pedley, R. B. Bagshawe, K. D. Melton, R. G. Alwan, S. M. Sherwood, R. F. Br J Cancer Research Article Carboxypeptidase G2, a zinc metalloenzyme isolated from Pseudomonas sp. strain RS-16, which catalyses the hydrolytic cleavage of reduced and non-reduced folates to pteroates and L-glutamate, has been linked to a monoclonal antibody (W14A) raised to human chorionic gonadotrophin. The coupling efficiency and retention of antibody and enzymatic activities are compared for three separate methods of preparing 1:1 conjugates. Preliminary in vitro studies on the cytotoxicity of the free enzyme and the conjugated enzyme towards JAR choriocarcinoma cells are reported. Despite the limitations of the in vitro model, it could be demonstrated that a significant proportion of 10(6) choriocarcinoma cells lost viability when exposed to either free or conjugated enzyme for 72 hours at concentrations of carboxypeptidase G2 of 1-3 units ml-1 of medium. Nature Publishing Group 1986-03 /pmc/articles/PMC2001364/ /pubmed/3964540 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Searle, F. Bier, C. Buckley, R. G. Newman, S. Pedley, R. B. Bagshawe, K. D. Melton, R. G. Alwan, S. M. Sherwood, R. F. The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitro. |
title | The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitro. |
title_full | The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitro. |
title_fullStr | The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitro. |
title_full_unstemmed | The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitro. |
title_short | The potential of carboxypeptidase G2-antibody conjugates as anti-tumour agents. I. Preparation of antihuman chorionic gonadotrophin-carboxypeptidase G2 and cytotoxicity of the conjugate against JAR choriocarcinoma cells in vitro. |
title_sort | potential of carboxypeptidase g2-antibody conjugates as anti-tumour agents. i. preparation of antihuman chorionic gonadotrophin-carboxypeptidase g2 and cytotoxicity of the conjugate against jar choriocarcinoma cells in vitro. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001364/ https://www.ncbi.nlm.nih.gov/pubmed/3964540 |
work_keys_str_mv | AT searlef thepotentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT bierc thepotentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT buckleyrg thepotentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT newmans thepotentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT pedleyrb thepotentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT bagshawekd thepotentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT meltonrg thepotentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT alwansm thepotentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT sherwoodrf thepotentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT searlef potentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT bierc potentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT buckleyrg potentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT newmans potentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT pedleyrb potentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT bagshawekd potentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT meltonrg potentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT alwansm potentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro AT sherwoodrf potentialofcarboxypeptidaseg2antibodyconjugatesasantitumouragentsipreparationofantihumanchorionicgonadotrophincarboxypeptidaseg2andcytotoxicityoftheconjugateagainstjarchoriocarcinomacellsinvitro |